Shao JW, Liu RY, Yi JL, Lu JP, Huang WL. Construction of recombinant eukaryotic expression vector for human endostatin and its expression in liver cancer cell line SMMC-7721.
Shijie Huaren Xiaohua Zazhi 2005;
13:1679-1683. [DOI:
10.11569/wcjd.v13.i14.1679]
[Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
AIM: To construct the recombinant eukaryotic expression vector for human endostatin and express it in human liver cancer cell line SMMC-7721, and to observe its anti-angiogenesis activity in vitro.
METHODS: Human endostatin cDNA containing interleukin-2 (IL-2) secreting peptide was cloned into eukaryotic expression plasmid pcDNA3.0 to construct recombinant plasmid pCD-sEndo. The plasmid pCD-sEndo was transfected intoSMMC-7721 cells by cationic liposome. The positive cell clones were selected by G418 and named SMMC/sEndo. The expression of endostatin protein was analyzed by Western-blot. The activity of endostatin protein in the supernatant of SMMC/sEndo cells was explored by the angiogenesis experiment of chicken chorioallantoic membrane (CAM).
RESULTS: The eukaryotic expression vector pCD-sEndo was successfully constructed and was confirmed by enzyme digestion and sequence analysis. The endostatin protein was expressed in the supernatant of SMMC/sEndo cells, about 20 ku in size. No expression of endostatin protein was found in the control cells. There were fewer blood vessels in the CAM treated with endostatin protein, and the blood vessel density markedly decreased. Furthermore, the density decreased with the increase of endostatin protein.
CONCLUSION: The recombinant eukaryotic expression vector is correctly constructed. The human endostatin protein with the activity of anti-angiogenesis can be expressed and secreted in the supernatant of SMMC-7721 cells tranfected with pCD-sEndo.
Collapse